Skip to content
Breaking News Desk Editorial

DCGI Orders Strict Pharma Testing After Children Die from Contaminated Cough Syrup in India

DCGI Orders Strict Pharma Testing After Children Die from Contaminated Cough Syrup in India
Abhishek Sharma
Founder & Editor-in-Chief
Published: Updated: 2 min read
AdvertisementAdvertisement

Overview

The Drugs Controller General of India (DCGI) has issued a strong advisory to state and Union Territory drug controllers to ensure strict testing of pharmaceutical raw materials and finished medicines before they are released to the market. This follows tragic incidents where children died after consuming contaminated cough syrup.

What Happened?

  • In Madhya Pradesh, 20 children died and five remain in critical condition due to kidney infections linked to cough syrup containing Diethylene Glycol and Ethylene Glycol.
  • In Rajasthan, three children allegedly died after consuming similar cough syrup.
  • Inspections revealed that manufacturers failed to test each batch of raw materials and active ingredients before production.

Why Is This Important?

These chemicals — Diethylene Glycol and Ethylene Glycol — are toxic and should never be present in medicines. Batch testing of raw materials and finished products is crucial to ensure safety and prevent tragedies.

DCGI Advisory Highlights

  1. Drug controllers must ensure compliance with testing before market release.
  2. Each batch of raw materials and final products must be tested in approved laboratories.
  3. Manufacturers must keep proper records of all testing.
  4. Only materials from reliable, approved vendors should be used.
  5. Regular inspections must confirm adherence to these rules.

Frequently Asked Questions

What caused these children’s deaths?

Contamination of cough syrup with toxic chemicals Diethylene Glycol and Ethylene Glycol caused kidney infections, leading to fatalities.

What actions are being taken?

The DCGI has instructed state and UT drug controllers to enforce strict batch testing of raw materials and medicines, and ensure manufacturers follow proper safety protocols.

How can such incidents be prevented?

Manufacturers must conduct mandatory testing for every batch, maintain accurate records, and use only high-quality raw materials from approved vendors.

Conclusion

This tragedy highlights the urgent need for stricter pharmaceutical safety checks in India. The DCGI’s directive aims to prevent future incidents and safeguard public health.

⚡ Prime Member Exclusive
Ad-Free News + 100+ Market Tools
No ads. Screener, FII/DII, SLBM, MTF — all in one dashboard.
Join Prime →
Abhishek Sharma
Founder & Editor-in-Chief

Abhishek Sharma

I’m Abhishek Sharma, an Advocate based in Delhi, entrepreneur, investor, and founder of BigBreakingWire. I am an enrolled Advocate with a strong interest in entrepreneurship, media, and technology. I founded BigBreakingWire, a digital news platform covering breaking news, business, financial markets, companies, and important developments in India and around the world. I also have a software company and take an active interest in technology, software, AI, digital products, and new business ideas. As an investor, I’m interested in discovering and investing in promising businesses and startups. I look for good ideas, strong founders, practical business models, and opportunities with long-term potential. I enjoy building businesses, learning about new industries, and connecting with people who are working on interesting ideas and opportunities. Advocate | Entrepreneur | Investor | Founder & Editor-in-Chief, BigBreakingWire

Last reviewed by Abhishek Sharma on February 7, 2026

Disclaimer: BigBreakingWire provides news and informational content for general educational purposes only. The information presented on this website does not constitute financial, investment, tax, or legal advice. Readers should consult qualified professionals before making any financial decisions. BigBreakingWire, its authors, and editors are not responsible for any financial losses or damages arising from the use of information on this site.

Discussion

Share your take — react and comment in seconds, no login needed.

0 comments

Loading discussion…

Be civil — abusive or promotional comments get removed. No login required.

⚡ Prime Member Exclusive
Ad-Free News + 100+ Market Tools
No ads. Screener, FII/DII, SLBM, MTF — all in one dashboard.
Join Prime →